July 26, 2022
An urgent request: Ask cBHT prescribers to sign our physician letter to FDA!
If compounding hormones is a part of your compounding business, we know you’re concerned about FDA’s implicit threat to introduce restrictions.
We’re hearing from members of Congress that they’ve heard a lot from pharmacists on this issue, but not much at all from physicians.
To address that issue, we’re asking for your help in engaging physicians in the campaign to save compounded hormones. If you have a database of cBHT prescribers, we’re asking you to reach out to them and urge them to sign a joint physician letter to FDA Commissioner Robert Califf (and to congressional leaders) expressing concern about FDA’s stated intention to rely on the discredited NASEM report in considering restrictions to compounded hormones.
Learn more here.
